Schering-Plough
SGP
#545
Rank
โ‚น4.196 T
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Schering-Plough (SGP) - Total debt

Total debt on the balance sheet as of December 2008 : โ‚น742.79 Billion

According to Schering-Plough's latest financial reports the company's total debt is โ‚น742.79 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Schering-Plough - Total debt on balance sheet (from 1996 to 2008)

Total debt by year

Year Total debt Change
2008-12-31โ‚น392.97 B
2006-12-31โ‚น117.63 B-28.91%
2005-12-31โ‚น165.46 B-3.54%
2004-12-31โ‚น171.54 B9.75%
2003-12-31โ‚น156.30 B-24.43%
2002-12-31โ‚น206.82 B125.6%
2001-12-31โ‚น91.67 B-25.31%
2000-12-31โ‚น122.74 B
1998-12-31โ‚น87.25 B-9.57%
1997-12-31โ‚น96.48 B141.54%
1996-12-31โ‚น39.94 B